Latest News

Access Health Louisiana uses animated series and radio to educate communities on HIV, HCV, and public health.

Q1 2022 assessment of HCV treatment access in ADAPs and Medicaid with DAA coverage and harm reduction data.

CANN announces 2022 organizational changes including rebranding and launching the 340B Action Center.

CANN reflects on 2021 advocacy spanning 340B drug pricing, HIV, hepatitis C, and substance use disorder policy.

FDA reclassifies HCV testing to reduce regulatory burden and enable new test makers to enter market.

Q4 2021 Watch covering HCV drug formulary updates, ADAP and Medicaid changes, and pandemic impact on care.

Global Fund report shows COVID-19 reduced HIV/HCV program efficacy while South Africa tripled ART coverage.

31,000 Veterans with HIV face unique barriers including comorbidities and HCV rates 3x the general population.

Analysis of hepatitis B vaccine efficacy and revaccination protocols for people living with HIV.

COVID-19 strains public health efforts addressing HIV outbreaks, diverting resources from the domestic epidemic.

Post-PHE planning for Medicaid redetermination: extended timelines and navigator support for safety net care.

Study explores social-spatial networks and HIV/HCV diagnosis rates among homeless and injection drug users.

Nobel laureate's HCV vaccine development targeting 2029 offers hope alongside access equity challenges.

WHO 2030 HCV elimination goal at risk; only 5 of 110 countries on track as COVID-19 disrupts progress.

Q3 2021 quarterly review of HCV drug access across ADAPs and Medicaid with harm reduction program updates.

CANN roundtable discusses pandemic's impacts on HIV, HCV, STI, and SUD programs and funding weaknesses.

Study of 109,283 patients links HIV status and viral hepatitis coinfection to significantly increased liver cancer rates.

Restrictive Medicaid policies limit HCV treatment access through fibrosis restrictions and sobriety requirements.

UNAIDS report highlights HIV-HCV coinfection rates among people who inject drugs globally and in the US.

Supreme Court allows states to ration hepatitis C care in prisons, setting dangerous precedent for incarcerated people.